Evidence map›Paper›PMID 27454675›Full record

SynthesisExperimental and clinical psychopharmacology2016

Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Marisa E Marraccini, Lisa L Weyandt, Joseph S Rossi, Bergljot Gyda Gudmundsdottir

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Experimental and clinical psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Changes in processing speed during early abstinence from alcohol dependence.Journal of psychopharmacology (Oxford, England) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontoinsular Network Markers of Current and Future Adolescent Mood Health.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2019
    Article
  18. A single dose of cocaine enhances prospective memory performance.Journal of psychopharmacology (Oxford, England) · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marisa E MarracciniDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Bradley Hasbro Research Center.
Lisa L WeyandtDepartment of Psychology, The University of Rhode Island.
Joseph S RossiDepartment of Psychology, The University of Rhode Island.
Bergljot Gyda GudmundsdottirDepartment of Psychology, The University of Rhode Island.

Funding

Biomarkers, Social and Affective Predictors of Suicidal Thoughts and Behaviors in AdolescentsR01MH105379 · NIMH · RHODE ISLAND HOSPITAL · PI NUGENT, NICOLE R · 2015 to 2019
$3.3M
URI Central Behavior Change Research FacilityG20RR030883 · NCRR · UNIVERSITY OF RHODE ISLAND · PI DEHAYES, DONALD H · 2010 to 2010
$2.8M
NCRR NIH HHS G20 RR030883NIMH NIH HHS R01 MH105379
6 · The paper itself

Abstract

Increasing numbers of adults, particularly college students, are misusing prescription stimulants primarily for cognitive/academic enhancement, so it is critical to explore whether empirical findings support neurocognitive benefits of prescription stimulants. Previous meta-analytic studies have supported small benefits from prescription stimulants for the cognitive domains of inhibitory control and memory; however, no meta-analytic studies have examined the effects on processing speed or the potential impairment on other domains of cognition, including planning, decision-making, and cognitive perseveration. Therefore, the present study conducted a meta-analysis of the available literature examining the effects of prescription stimulants on specific measures of processing speed, planning, decision-making, and cognitive perseveration among healthy adult populations. The meta-analysis results indicated a positive influence of prescription stimulant medication on processing speed accuracy, with an overall mean effect size of g = 0.282 (95% CI [0.077, 0.488]; n = 345). Neither improvements nor impairments were revealed for planning time, planning accuracy, advantageous decision-making, or cognitive perseveration; however, findings are limited by the small number of studies examining these outcomes. Findings support that prescription stimulant medication may indeed act as a neurocognitive enhancer for accuracy measures of processing speed without impeding other areas of cognition. Considering that adults are already engaging in illegal use of prescription stimulants for academic enhancement, as well as the potential for stimulant misuse to have serious side effects, the establishment of public policies informed by interdisciplinary research surrounding this issue, whether restrictive or liberal, is of critical importance. (PsycINFO Database Record

Indexed as

AmphetaminesCentral Nervous System StimulantsCognitionDecision MakingHumansMethylphenidateAmphetaminesCentral Nervous System StimulantsMethylphenidate

Identifiers

PMID27454675
PMCPMC4968888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.